Screener
aTyr Pharma ATYR Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 4) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value per share; 5,000,000 undesignated authorized shares as of June 30, 2026 (unaudited) and December 31, 2025, respectively; no shares issued or outstanding as of June 30, 2026 (unaudited) and December 31, 2025 | — | — |
| Common stock, $0.001 par value per share; 340,000,000 and 170,000,000 authorized shares as of June 30, 2026 (unaudited) and December 31, 2025, respectively; 98,087,425 and 98,031,014 issued and outstanding shares as of June 30, 2026 (unaudited) and December 31, 2025, respectively | 98 | 98 |
| Additional paid-in capital | 676,022 | 673,554 |
| Accumulated other comprehensive loss | (68) | (8) |
| Accumulated deficit | (627,264) | (606,164) |
| Total aTyr Pharma, Inc. stockholders’ equity | 48,788 | 67,480 |
Item 1. Financial Statements
FAQ
- What is aTyr Pharma's common stock?
- aTyr Pharma (ATYR) reported common stock of $98K in Q2 2026.
- How has aTyr Pharma's common stock changed year-over-year?
- aTyr Pharma's common stock increased by 5.4% year-over-year, from $93K to $98K.
- What is the long-term trend for aTyr Pharma's common stock?
- Over 5 years (2020 to 2025), aTyr Pharma's common stock has grown at a 54.9% compound annual growth rate (CAGR), from $11K to $98K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about aTyr Pharma's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude